NeuPath Q3 2026 adjusted EBITDA falls 5% year over year to CAD 1.4 million
NeuPath Q3 2026 adjusted EBITDA falls 5% year over year to CAD 1.4 million NeuPath Health report
NeuPath Q3 2026 adjusted EBITDA falls 5% year over year to CAD 1.4 million NeuPath Health report